Skip to main content

Oregon State Flag An official website of the State of Oregon »

Legislative reports

2025 Generic Drug Report

The Oregon Prescription Drug Affordability Board approved the PDAB Generic Drug Report 2025 for sending to the Oregon Legislature in accordance with ORS 646A.697. The report includes:

  • Background
  • Pricing, market trends, and issues
  • Shortages and effects on the health care system
  • Pricing effect on Medicare and Medicaid spending
  • Market concerns with importation and tariffs
  • Group purchasing organization and pharmacy benefit manager practices
  • Overview of PBM-owned generic and biosimilar manufacturing
  • Conclusion